Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
Courtney L. Jones(University of Colorado Anschutz Medical Campus), Craig T. Jordan(University of Colorado Anschutz Medical Campus), Biniam Adane(University of Colorado Anschutz Medical Campus), Julie A. Reisz(University of Colorado Anschutz Medical Campus), Dominik Reinhold(University of Colorado Denver), Daniel A. Pollyea(University of Colorado Denver), Haobin Ye(University of Colorado Anschutz Medical Campus), James DeGregori(University of Colorado Denver), Rachel Culp‐Hill(University of Colorado Denver), Travis Nemkov(Touch of Life Technologies (United States)), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Brett M. Stevens(University of Rochester), Anna Krug(University of Colorado Anschutz Medical Campus), Nabilah Khan(University of Colorado Anschutz Medical Campus), Clayton A. Smith(University of Colorado Anschutz Medical Campus), Shanshan Pei(University of Colorado Anschutz Medical Campus)
Cited by 565
Related Papers
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
|Blood|2005|675
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655